Optical biometry is the most precise

Article

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Dr Peiyang Shen et al., Division of Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou, China, compiled a comparative evaluation on optical biometry (OLCR), partial coherence interferometry (PCI) applanation ultrasound biometry in highly myopic eyes.

Biometric measurements were recorded in patients with a spherical equivalence (SE) of -6.00 D or higher and an axial length (AL) of more than 25.0 mm. OLCRS was used to obtain AL and anterior chamber depth (ACD) and compared to the results obtained using PCI and applanation A-scan ultrasound. Bland-Altman analyses were used to evaluate repeatability.

The coefficient of variations (CoVs) for OLCR, PCI and applanation ultrasound were 0.06%, 0.07%, and 0.20%, respectively. ACD was recorded at 0.29 mm, 0.53 mm and 0.51 mm, respectively. Mean radius of corneal curvature was the most similar between OLCR and PCI, with a limit of agreement of 0.12 mm.

The AL and ACD measurements obtained by optical biometry were more precise and repeatable, compared to measurements obtained from applanation biometry.

The abstract can be viewed in the latest issue of the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.